Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension

The investigators hypothesized combination therapy would be superior to monotherapy.

Completed

Looking for future studies?

Key information

Conditions

Hypertension Cardiovascular Diseases Glucose Metabolism Disorders Hyperinsulinism Hypersensitivity Immune System Diseases Insulin Resistance Metabolic Diseases Nutritional and Metabolic Diseases Vascular Diseases

Age range

25 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Gil Medical Center

Incheon, 405-760, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Hypertension

Exclusion criteria

Chronic renal disease
Severe hypertension

Treatment and study plan

statin, amlodipine

Drug

Sponsors and collaborators

Lead sponsor

Gachon University Gil Medical Center

Other

Registry information

Important dates

Study start: 2004
Study completion: 2008
First posted: Aug 26, 2008
Registry last updated: Aug 29, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed